Novozymes A/S (OTCMKTS:NVZMY) Shares Gap Up - What's Next?

Key Points

• Shares gapped up — Novozymes opened at $54.53 versus the prior close of $52.81 and last traded around $54.36 on Friday with volume of about 19,063 shares.
• Quarterly results missed expectations — The company reported EPS of $0.35 versus analysts' $0.79 estimate and revenue of $1.18 billion versus $1.22 billion, with a net margin of 13.96% and ROE of 6.38%.
• Valuation and balance-sheet snapshot — Market cap $22.46 billion, P/E 38.7 and PEG 0.97, 50-day/200-day moving averages of $60.40/$61.74, current ratio 1.61 and debt/equity 0.26.

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) shares gapped up prior to trading on Friday . The stock had previously closed at $52.81, but opened at $54.53. Novozymes A/S shares last traded at $54.3620, with a volume of 19,063 shares.

Novozymes A/S Stock Performance

The company has a current ratio of 1.61, a quick ratio of 1.00 and a debt-to-equity ratio of 0.26. The firm has a fifty day moving average price of $60.40 and a 200 day moving average price of $61.74. The firm has a market cap of $22.46 billion, a PE ratio of 38.70, a price-to-earnings-growth ratio of 0.97 and a beta of 1.11.

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) last announced its quarterly earnings data on Wednesday, February 25th. The biotechnology company reported $0.35 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.79 by ($0.44). Novozymes A/S had a net margin of 13.96% and a return on equity of 6.38%. The firm had revenue of $1.18 billion during the quarter, compared to analysts' expectations of $1.22 billion. As a group, equities research analysts expect that Novozymes A/S will post 1.82 earnings per share for the current fiscal year.

About Novozymes A/S

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company's product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.